Private Label Boswellia Standardized, 90 Capsules

Private Label Standardized Boswellia Capsules for Joint Comfort and Mobility Lines

Private Label Boswellia Standardized is a 90-count capsule containing boswellia extract standardized to 65% boswellic acids at 260 mg, manufactured to order for supplement brands by BioB Manufacturing in a GMP-certified facility in Hauppauge, New York, made in the USA from globally sourced ingredients, with flexible minimums, custom packaging and full formulation support from concept to finished goods.

This is a specification-forward SKU, and that is its commercial point. Boswellia is widely available as a generic capsule with no standardization declared, which leaves the buyer no way to compare one bottle against another except on price. A standardized extract with a stated boswellic acid percentage and a stated milligram figure gives a brand something concrete to put on the front panel and in its retail sell sheet. It suits joint comfort and mobility ranges, active-lifestyle and recovery lines, and premium botanical assortments aimed at customers who read specifications before they read marketing.

Specifications

Product type: Standardized botanical extract capsule, finished bottled goods

Botanical / actives: Boswellia gum resin (Boswellia serrata), standardized to 65% boswellic acids at 260 mg

Base: Encapsulated standardized extract

Size: 90 capsules per bottle

Manufacturing: Made in the USA from globally sourced ingredients

Facility: GMP-certified (Hauppauge, NY)

Certifications: NSF, USDA Organic, Kosher, and Halal available

Minimum order: 300,000 capsules or tablets total; request a quote for exact MOQ and price breaks

Customization: Custom packaging and full formulation support

Private label: Yes, concept to finished goods

What Is a Standardized Botanical Extract?

A standardized botanical extract is an extract processed and verified to contain a declared percentage of a specified marker compound, so that every batch delivers the same measured composition rather than whatever the raw material happened to carry that season. Unstandardized botanical material varies with growing region, harvest timing, plant age and storage, which means two bottles of generic boswellia capsules can differ substantially even when both are honestly labeled. Standardization removes that variability from the brand's supply chain and from the customer's experience. For this SKU the declared specification is 65% boswellic acids at 260 mg, which is what allows a retail buyer, a formulator or a customer to compare like with like. Commercially it changes the conversation: an unstandardized capsule competes on price per bottle, while a standardized capsule competes on a specification, which is a far better position for a brand trying to hold margin.

Market Demand

Joint and mobility products are one of the most durable categories in supplements, driven by an aging population and by younger active consumers who buy recovery products rather than remedies. Grand View Research values the global bone and joint health supplements market at USD 14.2 billion in 2024 and USD 16.2 billion in 2026, reaching USD 27.2 billion by 2033 at a 7.6% CAGR. The ingredient shift inside that category matters as much as its size: Grand View Research puts the global botanical supplements market at USD 38.2 billion in 2024 growing to USD 67.0 billion by 2030 at a 9.9% CAGR, growing faster than the joint category itself, which reflects buyers moving from conventional joint ingredients toward plant-based ones. A standardized boswellia capsule sits exactly at that intersection, which is the strongest place a brand can enter this shelf.

Private Label Opportunity

Standardized ingredients are where private label stops being a cost decision and becomes a quality decision. A brand that sources generic boswellia is buying a commodity and will be priced like one; a brand that sources a standardized extract at a declared specification has a product story that survives a retail buyer meeting. BioB Manufacturing supplies this as finished 90-count bottles under the brand's own label, so a brand gets the standardized material, the encapsulation, the bottling and the batch documentation without running a sourcing program for a resin extract from an Indian species. Formulation support is available if the brand wants boswellia as the anchor of a broader joint formula rather than as a standalone SKU, and companion products in the same range can be produced in the same facility so the finished set reads as one line.

Competitive Landscape

The joint shelf splits into a few well-defined groups. Glucosamine and chondroitin combinations still occupy the most facings and the most legacy brand recognition, but they are mature and heavily discounted. Turmeric and curcumin products dominate the botanical end and have become so crowded that differentiation is largely a packaging exercise. Generic unstandardized boswellia capsules sit at the value end. Collagen has pulled a share of the category toward powders and drinks. A standardized boswellia capsule is positioned against all of these as the specification-led botanical alternative: it is not the ingredient every competitor already carries, it is not a commodity capsule with nothing declared, and unlike a powder or drink it fits the pill-format habits of the core joint-category buyer. For brands that already list turmeric, boswellia is the logical second botanical rather than a duplicate.

Why Brands Choose This Formula

Brands choose this formula because the specification does the selling. A front panel that can state 65% boswellic acids at 260 mg gives sales teams, retail buyers and category managers a concrete number to work with, and gives the customer a reason to pick this bottle over the one beside it. Behind that number, the standardized extract, the encapsulation, the bottling and the quality documentation all run through one GMP-certified facility in Hauppauge, New York, made in the USA from globally sourced ingredients, with NSF, USDA Organic, Kosher and Halal certifications available where the brand's positioning calls for them. The capsule minimum of 300,000 capsules or tablets total is counted across the project rather than per SKU, so a brand launching a joint range of several products reaches it more readily than a single-product launch would suggest.

Common Buyer Questions

What is a private label boswellia capsule?

It is a finished 90-count bottle of standardized boswellia extract capsules, manufactured by BioB Manufacturing and sold under your brand's name rather than ours. You control the label, packaging and positioning; we handle the standardized extract, encapsulation, bottling, batch documentation and delivery of finished goods from our Hauppauge, New York facility, so the product arrives ready to list and sell.

What is the standardization on this extract?

The extract is standardized to 65% boswellic acids at 260 mg, and that specification is what makes the SKU comparable batch to batch and bottle to bottle. Standardization is verified as part of production, and the specification sheet issued with your quote confirms the finished figures your supplement facts panel and marketing materials should be built from.

What part of the boswellia plant is used?

The gum resin is used, not the leaf, bark or root. Boswellia serrata is a tree native to India whose resin has been collected and used in Ayurvedic tradition for centuries, and naming the gum resin specifically on your label matters because several Boswellia species are traded and the resin is the material the standardization applies to.

What is your minimum order quantity (MOQ)?

Minimum order quantities vary by format. Liquid products under 8 oz start at 5,000 units; 8 oz and larger liquids start at 2,500 units. Capsule and tablet products have a minimum of 300,000 capsules or tablets total. Request a quote and we'll confirm exact MOQ and price breaks for your project.

Can the packaging and label be customized?

Yes. Bottle, cap, label artwork and carton are specified by you, and our team supports artwork setup and compliance review of the finished panel. On a standardized SKU most brands give the specification prominent front-panel treatment, since that is the detail that differentiates the product from generic boswellia on the same shelf.

Is the product manufactured to certified quality standards?

Yes. Encapsulation and bottling take place in a GMP-certified facility in Hauppauge, New York, and the product is made in the USA from globally sourced ingredients. NSF, USDA Organic, Kosher and Halal certifications are available depending on your specification, and batch documentation accompanies production for your quality and retail partners.

What wellness category does this product fit?

Brands position standardized boswellia within joint comfort and mobility ranges, active-lifestyle and recovery lines, and premium Ayurvedic or botanical assortments. It also works as the botanical entry in a joint range otherwise built on conventional ingredients. Positioning should stay in traditional-use and category language rather than making health outcome claims.

Can BioB MFG manufacture this as a private label supplement?

Yes. BioB Manufacturing supplies standardized boswellia as a finished private label capsule product from concept to bottled goods, with formulation support if you want it built into a multi-ingredient joint formula. Capsule projects carry a minimum of 300,000 capsules or tablets total, and we will confirm exact minimums and price breaks for your project when you request a quote.

Updated September 2026